Early detection and diagnosis is a must in secondary prevention of melanoma and other cancerous lesions of the skin. In this work, we present an online, reservoir-based, non-parametric estimation and classification model that allows for this functionality on pigmented lesions, such that detection thresholding can be tuned to maximize accuracy and/or minimize overall false negative rates. This system has been tested in a dataset consisting of 116 patients and a total of 124 hyperspectral images of nevi, raised nevi and melanomas, detecting up to 100% of the suspicious lesions at the expense of some false positives.
Prototyping hyperspectral imaging devices in current biomedical optics research requires taking into consideration various issues regarding optics, imaging, and instrumentation. In summary, an ideal imaging system should only be limited by exposure time, but there will be technological limitations (e.g., actuator delay and backlash, network delays, or embedded CPU speed) that should be considered, modeled, and optimized. This can be achieved by constructing a multiparametric model for the imaging system in question. The article describes a rotating-mirror scanning hyperspectral imaging device, its multiparametric model, as well as design and calibration protocols used to achieve its optimal performance. The main objective of the manuscript is to describe the device and review this imaging modality, while showcasing technical caveats, models and benchmarks, in an attempt to simplify and standardize specifications, as well as to incentivize prototyping similar future designs.
Many well-known algorithms for the color enhancement of hyperspectral measurements in biomedical imaging are based on statistical assumptions that vary greatly with respect to the proportions of different pixels that appear in a given image, and thus may thwart their application in a surgical environment. This article attempts to explain why this occurs with SVD-based enhancement methods, and proposes the separation of spectral enhancement from analysis. The resulting method, termed affinity-based color enhancement, or ACE for short, achieves multi-and hyperspectral image coloring and contrast based on current spectral affinity metrics that can physically relate spectral data to a particular biomarker. This produces tunable, real-time results which are analogous to the current state-of-the-art algorithms, without suffering any of their inherent context-dependent limitations. Two applications of this method are shown as application examples: vein contrast enhancement and high-precision chromophore concentration estimation.
Is it possible to find deterministic relationships between optical measurements and pathophysiology in an unsupervised manner and based on data alone? Optical property quantification is a rapidly growing biomedical imaging technique for characterizing biological tissues that shows promise in a range of clinical applications, such as intraoperative breast-conserving surgery margin assessment. However, translating tissue optical properties to clinical pathology information is still a cumbersome problem due to, amongst other things, inter-and intrapatient variability, calibration, and ultimately the nonlinear behavior of light in turbid media. These challenges limit the ability of standard statistical methods to generate a simple model of pathology, requiring more advanced algorithms. We present a data-driven, nonlinear model of breast cancer pathology for real-time margin assessment of resected samples using optical properties derived from spatial frequency domain imaging data. A series of deep neural network models are employed to obtain sets of latent embeddings that relate optical data signatures to Manuscript
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.